 This preliminary, prospective, dose escalating clinical study will evaluate the safety and potential efficacy of Autologous Muscle Derived Cells for Gastro-Intestinal Repair AMDC-GIR for the treatment of tongue dysphagia TD that develops following treatment for head and neck cancer. 